NYTech
Companies
Companyhealthcare ai

Rumi Scientific

Rumi Scientific is a research-driven company focused on the discovery of drugs and innovative treatments for human genetic diseases affecting the central nervous system. We have created an exciting human organoid-based platform that can be used for agnostic drug discovery and can be translated at the level of high-throughput screening. We have unlocked the full potential of human organoid technology for the discovery of tomorrow’s therapeutics. Our platform harnesses the power of embryonic ste[1][2]

Visit website Suggest an update
2017 Founded5 People on the graph

Overview

Rumi Scientific is a biotechnology company operating in the New York artificial intelligence sector[1]. Founded in 2017, the company focuses on drug discovery and development of treatments for human genetic diseases affecting the central nervous system[2]. The company operates a human organoid-based platform designed for drug discovery applications that can be scaled to high-throughput screening levels[2]. According to available information, Rumi Scientific has approximately 17 employees[3].

Business address: 430 E 29th St, New York, New York, 10016. [6]

Growth & traction

LinkedIn lists 17 people working at Rumi Scientific. [4]

Leadership & org chart

Focus

  • Rumi Scientific describes itself as "Leveraging the power of mother nature and artificial intelligence to fast-track drug discovery for genetic diseases.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.